{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:25:15Z","timestamp":1770888315935,"version":"3.50.1"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,10,23]]},"DOI":"10.1001\/jama.2018.14955","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T06:13:57Z","timestamp":1540448037000},"page":"1670","source":"Crossref","is-referenced-by-count":32,"title":["Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent"],"prefix":"10.1001","volume":"320","author":[{"given":"Tanima","family":"De","sequence":"first","affiliation":[{"name":"Northwestern University, Department of Pharmacology, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Alarcon","sequence":"additional","affiliation":[{"name":"Northwestern University, Department of Pharmacology, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenndy","family":"Hernandez","sequence":"additional","affiliation":[{"name":"University of Chicago, Section of Genetic Medicine, Department of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Liko","sequence":"additional","affiliation":[{"name":"University of Illinois College of Pharmacy, Department of Pharmacy Practice, Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa H.","family":"Cavallari","sequence":"additional","affiliation":[{"name":"University of Florida, College of Pharmacy, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio D.","family":"Duarte","sequence":"additional","affiliation":[{"name":"University of Florida, College of Pharmacy, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoli A.","family":"Perera","sequence":"additional","affiliation":[{"name":"Northwestern University, Department of Pharmacology, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"jpc180008r3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1345\/aph.1E566","article-title":"The influence of ethnicity on warfarin dosage requirement.","volume":"39","author":"Dang","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"4","key":"jpc180008r4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mcna.2005.02.005","article-title":"Epidemiology of stroke in African Americans and Hispanic Americans.","volume":"89","author":"Pandey","year":"2005","journal-title":"Med Clin North Am"},{"key":"jpc180008r5","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism.","volume":"123","author":"White","year":"2009","journal-title":"Thromb Res"},{"issue":"10","key":"jpc180008r6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/FPC.0000000000000298","article-title":"Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.","volume":"27","author":"Limdi","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"jpc180008r7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","article-title":"The largest prospective warfarin-treated cohort supports genetic forecasting.","volume":"113","author":"Wadelius","year":"2009","journal-title":"Blood"},{"issue":"19","key":"jpc180008r8","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1182\/blood-2010-08-300152","article-title":"Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.","volume":"117","author":"Campos","year":"2011","journal-title":"Blood"},{"issue":"1","key":"jpc180008r9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3324\/haematol.2011.050682","article-title":"Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIB? (Bolzano mutation).","volume":"97","author":"Noris","year":"2012","journal-title":"Haematologica"},{"issue":"3-4","key":"jpc180008r10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/(ISSN)1099-1069","article-title":"The V617F JAK2 mutation and the myeloproliferative disorders.","volume":"23","author":"Percy","year":"2005","journal-title":"Hematol Oncol"},{"issue":"7","key":"jpc180008r11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ejhg.2015.222","article-title":"Genome-wide association studies identify genetic loci for low von Willebrand factor levels.","volume":"24","author":"van Loon","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"9894","key":"jpc180008r12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0140-6736(13)60681-9","article-title":"Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.","volume":"382","author":"Perera","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"jpc180008r13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"4","key":"jpc180008r14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jth.2005.3.issue-4","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"jpc180008r15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/01.GIM.0000153664.65759.CF","article-title":"CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.","volume":"7","author":"Sanderson","year":"2005","journal-title":"Genet Med"},{"issue":"3","key":"jpc180008r16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nmeth.2832","article-title":"Functional annotation of noncoding sequence variants.","volume":"11","author":"Ritchie","year":"2014","journal-title":"Nat Methods"},{"issue":"4","key":"jpc180008r17","doi-asserted-by":"publisher","first-page":"e0122520","DOI":"10.1371\/journal.pone.0122520","article-title":"The HAS-BLED score identifies patients with acute venous thromboembolism at high risk of major bleeding complications during the first six months of anticoagulant treatment.","volume":"10","author":"Kooiman","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"jpc180008r18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1378\/chest.15-1509","article-title":"Recalibration of the HAS-BLED score: should hemorrhagic stroke account for one or two points?","volume":"149","author":"Nielsen","year":"2016","journal-title":"Chest"},{"issue":"17","key":"jpc180008r19","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans.","volume":"26","author":"Willer","year":"2010","journal-title":"Bioinformatics"},{"issue":"5","key":"jpc180008r20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00439-011-1118-2","article-title":"Evaluating the effective numbers of independent tests and significant P-value thresholds in commercial genotyping arrays and public imputation reference datasets.","volume":"131","author":"Li","year":"2012","journal-title":"Hum Genet"},{"issue":"18","key":"jpc180008r21","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","article-title":"LocusZoom: regional visualization of genome-wide association scan results.","volume":"26","author":"Pruim","year":"2010","journal-title":"Bioinformatics"},{"issue":"7319","key":"jpc180008r22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"issue":"29","key":"jpc180008r23","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1038\/sj.onc.1210211","article-title":"Global DNA methylation profiling reveals silencing of a secreted form of EPHA7 in mouse and human germinal center B-cell lymphomas.","volume":"26","author":"Dawson","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"jpc180008r24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.joen.2012.11.020","article-title":"Increased expression of EPHA7 in inflamed human dental pulp.","volume":"39","author":"Dong","year":"2013","journal-title":"J Endod"},{"issue":"7414","key":"jpc180008r25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature11232","article-title":"The accessible chromatin landscape of the human genome.","volume":"489","author":"Thurman","year":"2012","journal-title":"Nature"},{"issue":"8","key":"jpc180008r26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.yexcr.2010.02.029","article-title":"CHD1 remodelers maintain open chromatin and regulate the epigenetics of differentiation.","volume":"316","author":"Persson","year":"2010","journal-title":"Exp Cell Res"},{"key":"jpc180008r27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12867-015-0040-x","article-title":"TRIM28 as a novel transcriptional elongation factor.","volume":"16","author":"Bunch","year":"2015","journal-title":"BMC Mol Biol"},{"issue":"28","key":"jpc180008r28","doi-asserted-by":"publisher","first-page":"9820","DOI":"10.1073\/pnas.0404065102","article-title":"Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.","volume":"102","author":"Pr\u00e9vost","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"jpc180008r29","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1073\/pnas.142053899","article-title":"Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.","volume":"99","author":"Prevost","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"jpc180008r30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","article-title":"Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"jpc180008r31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jjcc.2014.03.006","article-title":"Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy.","volume":"64","author":"Suzuki","year":"2014","journal-title":"J Cardiol"},{"issue":"17","key":"jpc180008r32","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2008-09-176859","article-title":"Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"issue":"23","key":"jpc180008r33","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1161\/CIRCULATIONAHA.111.081489","article-title":"Reversal of warfarin: case-based practice recommendations.","volume":"125","author":"Garcia","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"jpc180008r34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","article-title":"Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.","volume":"31","author":"Greenland","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"jpc180008r1","volume-title":"Comparative Effectiveness of Warfarin and Newer Oral Anticoagulants for the Long-Term Prevention and Treatment of Arterial and Venous Thromboembolism","author":"Adam","year":"2012"},{"key":"jpc180008r2","first-page":"257S","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume-title":"Chest","author":"Schulman","year":"2008"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jama\/fullarticle\/2708114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T06:13:58Z","timestamp":1540448038000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.14955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":34,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,10,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.14955","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,23]]}}}